$40.02−1.65 (−3.96%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD
Septerna (SEPN) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
Sources Company filings FilingsHow we compute thisNot investment advice
17 figures withheld by our checks. Each blank figure names its reason.
Business engineGrowing fast: revenue compounds ~1644.5%/yr (FY23→FY25), net margin −106.4%.
The four lines that matter · FY23–FY25
Revenue ($M)▲4174.5%
46.0
FY23→FY25CAGR +1644.5%/yr
Net income ($M)▲31.9%
−48.9
FY23→FY25CAGR —
Free cash flow ($M)—
109.7
FY23→FY25CAGR —
Diluted EPS▲84.8%
−1.10
FY23→FY25CAGR —
What the income statement says · FY23–FY25
Where every revenue dollar goes · FY25 ($M)
-106¢ of every revenue dollar becomes profit.
Margin trend · direction beats level Operating Net
Net margin -106.4% is below the sector median. This filer reports no gross profit line, so that margin is not drawn.
The receipt · income statement · FY23–FY25 USD thousands except per-share & ratios · hover a line for its definition
USD thousands except per-share & ratios
| Line item | TTM † | FY25 | FY24 | FY23 | YoY | CAGR 23→25 |
|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||
Revenue | 96,268.0 | 45,951.0 | 1,075.0 | 151.0 | ▲4174.5% | +1644.5% |
Cost of revenue | — | 0.0 | 0.0 | 0.0 | — | — |
Gross profit | —A | —A | —A | —A | — | — |
Research & development | 133,084.0 | 97,584.0 | 65,337.0 | 35,979.0 | ▲49.4% | +64.7% |
Selling, general & admin | 36,572.0 | 29,164.0 | 16,561.0 | 9,722.0 | ▲76.1% | +73.2% |
Total operating expenses | 169,656.0 | 114,248.0 | 81,898.0 | −1,924.0 | ▲39.5% | — |
Operating incomefeeds ROC rank | −73,388.0 | −68,297.0 | −80,823.0 | 2,075.0 | ▲15.5% | — |
Other income, net | 20,332.0 | 19,430.0 | 8,527.0 | 2,796.0 | — | — |
Pretax income | −53,056.0 | −48,867.0 | −72,296.0 | 4,871.0 | ▲32.4% | — |
Income tax | 5,943.0 | 12.0 | −498.0 | 691.0 | — | −86.8% |
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings | −58,999.0 | −48,879.0 | −71,798.0 | 4,180.0 | ▲31.9% | — |
| Per share | ||||||
Diluted EPSbuyback-sensitive | −1.28 | −1.10 | −7.26 | 0.29 | ▲84.8% | — |
Diluted shares (mn) | 46.91 | 44.26 | 9.89 | 2.18 | ▲347.5% | +350.9% |
| Margins | ||||||
Gross margin | —A | —A | —A | —A | — | — |
Operating margin | −76.2% | −148.6% | −7518.4% | 1374.2% | ▲7369.8pp | −1522.8pp |
Net margin12th pct in Healthcare | −61.3% | −106.4% | −6678.9% | 2768.2% | ▲6572.5pp | −2874.6pp |
† TTM = trailing four quarters through 2026-09-30.A Withheld: cost of revenue is not on file, so the gross margin is not measured.
These lines feed the tenet checklists: see which gates passTenets →Margins & returns continue as sector-ranked ratiosStatistics →
Annual report filed 2026-03-09 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was Septerna's revenue last fiscal year?
Septerna reported revenue of $46.0M in fiscal 2025, up 4174.5% from fiscal 2024.
What was Septerna's net income?
Septerna reported net income of −$48.9M in fiscal 2025, a net margin of −106.4%.
Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

